Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nicola Crosbie"'
Autor:
Findlay Bewicke-Copley, Koorosh Korfi, Shamzah Araf, Brendan Hodkinson, Emil Kumar, Thomas Cummin, Margaret Ashton-Key, Sharon Barrans, Suzan van Hoppe, Cathy Burton, Mohamed Elshiekh, Simon Rule, Nicola Crosbie, Andrew Clear, Maria Calaminici, Hendrik Runge, Robert K. Hills, David W. Scott, Lisa M. Rimsza, Geetha Menon, Chulin Sha, John R. Davies, Ai Nagano, Andrew Davies, Daniel Painter, Alexandra Smith, John Gribben, Kikkeri N. Naresh, David R. Westhead, Jessica Okosun, Andrew Steele, Daniel J. Hodson, Sriram Balasubramanian, Peter Johnson, Jun Wang, Jude Fitzgibbon
Publikováno v:
Blood Advances. 7:845-855
Despite the effectiveness of immuno-chemotherapy, 40% of patients with diffuse large B-cell lymphoma (DLBCL) experience relapse or refractory disease. Longitudinal studies have previously focused on the mutational landscape of relapse but fell short
Autor:
Teresa Calimeri, Sara Steffanoni, Alice Laurenge, Christopher P. Fox, Carole Soussain, Christian Grommes, Maria Chiara Tisi, Jesca Boot, Nicola Crosbie, Carlo Visco, Luca Arcaini, Sridhar Chaganti, Alvaro J. Alencar, Daniele Armiento, Ilaria Romano, Marianna C. Sassone, Jorg Dietrich, Gilad Itchaki, Riccardo Bruna, Nicola S Fracchiolla, Laura Arletti, Adriano Venditti, Stephen Booth, Pellegrino Musto, Khe Hoang-Xuan, Tracy Batchelor, Kate Cwynarski, Andrés J.M. Ferreri
Publikováno v:
Blood. 140:3785-3787
Autor:
Sara Steffanoni, Teresa Calimeri, Alice Laurenge, Christopher P. Fox, Carole Soussain, Christian Grommes, Maria Chiara Tisi, Jesca Boot, Nicola Crosbie, Carlo Visco, Luca Arcaini, Sridhar Chaganti, Marianna C. Sassone, Alvaro Alencar, Daniele Armiento, Ilaria Romano, Jorg Dietrich, Gilad Itchaki, Riccardo Bruna, Nicola S. Fracchiolla, Laura Arletti, Adriano Venditti, Stephen Booth, Pellegrino Musto, Khê Hoang Xuan, Tracy T. Batchelor, Kate Cwynarski, Andrés J. M. Ferreri
Publikováno v:
British journal of haematologyREFERENCES. 199(4)
To optimise management of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection identifying high-risk patients and maintaining treatment dose intensity is an important issue in patients with aggressive lymphomas. In the present study
Autor:
Gita Thanarajasingam, Rory McCulloch, T.C. El-Galaly, Matthew J. Maurer, David A. Bond, Anita Kumar, Carlo Visco, D. Lewis, Aixiang Jiang, Nicola Crosbie, Simon Rule, Alina S. Gerrie, Joachim Baech, L. Kugathasan, Jonas Paludo, Michael J Buege, Diego Villa
Publikováno v:
Hematological Oncology. 39
Autor:
Safia Dawi, Andrew Robinson, Annabel McMillan, David Lewis, Simon Rule, Simon Bolam, Harshita Goradia, Samuel Harrison, Oliver Miles, Jonathan Lambert, Rosalynd Johnston, George A Follows, Matthew R. Wilson, Rory McCulloch, Toby A. Eyre, Wendy Osborne, Neil Phillips, Russell Patmore, David Dutton, Mark Bishton, Pam McKay, Nicola Crosbie, Anita Arasaretnam, Thomas Creasey, Amy A Kirkwood
Funder: Janssen Pharmaceuticals; Id: http://dx.doi.org/10.13039/100008897
Ibrutinib is an established treatment for relapsed/refractory (R/R) mantle cell lymphoma (MCL) and clinical trial data supports use at second line compared to later relaps
Ibrutinib is an established treatment for relapsed/refractory (R/R) mantle cell lymphoma (MCL) and clinical trial data supports use at second line compared to later relaps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1883ebb41b9604c2115161a2259a9494
Autor:
Carlo Visco, David L. Tucker, Annabel McMillan, Jonathan Lambert, Rory McCulloch, Rebecca Frewin, Neil Phillips, Simon Rule, Toby A. Eyre, Nicola Crosbie, Francesca Maria Quaglia
Patients with mantle cell lymphoma progressing on Bruton's tyrosine kinase inhibitor (BTKi) have very poor prognosis and there is currently no standard of care. In this retrospective cohort study, patients progressing on BTKi received R-BAC (rituxima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13757fdc2aa5cf0b4ea2bbb4bc6df91d
http://hdl.handle.net/11562/1051044
http://hdl.handle.net/11562/1051044
Autor:
Helen McCarthy, Deborah Turner, Nicola Crosbie, Nilima Parry-Jones, Simona Gatto, Roger G. Owen, Kim Linton, Shirley D'Sa, Jahanzaib Khwaja, Charalampia Kyriakou, Maria Atta, Suzanne O Arulogun, Aisha S Patel, Kirsty Cuthill, Guy Pratt, Jaimal Kothari, Josephine Crowe, Agapi Parcharidou, Jindriska Lindsay, Dima El-Sharkawi, Jeffery L. Smith
Publikováno v:
Blood. 138:1977-1977
Introduction: Waldenström's Macroglobulinaemia (WM) is a rare indolent B-cell lymphoma characterised by lymphoplasmacytic infiltrate with an IgM paraproteinaemia. Approximately 400 patients (pts) are diagnosed annually in the United Kingdom (UK). Na
Publikováno v:
British Journal of Haematology. 185:1002-1004
Autor:
Arunodaya Mohan, Mairi Walker, Luke Carter-Brzezinski, Chris Peet, Yezenash Ayalew, Israa Kaddam, Rita Perry, David Tucker, Mac Macheta, Hayder Hussein, Suriya Kirkpatrick, Julia Wolf, Cristina Crossette-Thambiah, Sarah Wharin, Dianne Plews, Melek Akay, Graham McIlroy, Alexandros Rampotas, Lydia Wilson, Sarah Davis, Jesca Boot, Regina Nolan, Akila Danga, Dan Mei Xu, Tina T. Biss, Dominique Chan-Lam, Jennifer Swieton, Tanya Freeman, Claire Burney, Keir Pickard, Sheila Jen, Chloe Knott, Alvin Katumba, Sam Ackroyd, Edward Blacker, Beena Salhan, Richard Buka, Duncan Murray, Charlotte Bradbury, Sally Chown, Quentin A. Hill, Mohd Sharin Mohd Noh, Chira Mustafa, Nicola Crosbie, Surenthini Suntharalingam, Katja Kimberger, Rory McCulloch, Thomas Skinner, Naoimh Herlihy, Daire Quinn, Abbas Zaidi, Haroon Miah, Louise Garth, Eleana Loizou, Robert Dunk, Dan Halperin, Michael J R Desborough, Nithya Prasannan, Rupert Hipkins, Holly Gibson, Christopher McDermott, Amelia Fisher, Yogesh Upadhye, Sarah Wexler, Hina Peter, Sarah Jaafar, Sine Janum, Andrew J. Doyle, John Willan, Sree Sreedhara, Han Wang, Jonathan Kerr, Laura Aiken, Tom Bull, Seda Cakmak, Jennifer Darlow, Martin Besser, Michael Joffe, Benjamin Bailiff, Susan Robinson, Charlotte Wilding, Atiqa Miah, Jorge Cartier, Ryan Mullally, Miroslab Kmonicek, Samuel Harrison, Marquita Camillieri, Vickie MacDonald, Jane Graham, Ayesha Ejaz, Ipek Cakmak, Upekha Badaguma, Michelle Melly, Christopher Bailey, Belen Sevillano, Francesca Crolla, Frances Seymour, Indrani Venkatadasari, Laura Magill, Claire Lentaigne, Pamela Oshinyemi, Katherine Leighton, Maipelo Kgologolo, Zara Sayar, Elissa K. Dhillon, Lindsay McLeod-Kennedy, Sophie Hanina, Alice Thorpe, David Wright, Andrew Hastings, Caroline Shrubsole, Gillian C. Lowe, Nichola Cooper, Shivali Walia, Gulnaz Shah, Abi Martin, David Sharpe, Anna Dillon, Georgina Talbot, Imogen Swart-Rimmer, Phillip L R Nicolson, Paul Greaves, Olivia Kreze, Gemma Scott, Amir Shenouda, Edmund Watson, Shereef Elmoamly, Roochi Trikha, Wayne Thomas, Rebecca Pryor, Hafiz Qureshi, Laura Batey, Abigail Atkin, Dimitris Tsitsikas, Suthesh Sivapalaratnam, Hajer Oun
Publikováno v:
Clinical Medicine. 19(Suppl 3)
Intravenous immunoglobulin (IVIg) is a common therapy for patients with immune thrombocytopenia (ITP). The initial response rate for IVIg is 80%[1][1] and is typically rapid, with some patients responding in 24 hours, although usually in 2–4 days.[
Autor:
Suzan Van Hoppe, Kikkeri N. Naresh, Jessica Okosun, Michael A. Bentley, Ai Nagano, Jun Wang, Jude Fitzgibbon, Margaret Ashton-Key, Chulin Sha, Andrew Davies, Lisa M. Rimsza, Menon Geetha, Emil Kumar, Findlay Bewicke-Copley, John G. Gribben, Andrew Clear, Daniel Painter, David R. Westhead, Thomas Cummin, Nicola Crosbie, Maria Calaminici, Simon Rule, Mohamed Elshiekh, David Scott, Shamzah Araf, Koorosh Korfi, Cathy Burton, Alexandra Smith, Peter Johnson, S. Barrans
Publikováno v:
Blood. 134:2769-2769
Background: Although diffuse large B cell lymphoma (DLBCL) can be cured using immuno-chemotherapy, 40% of patients experience relapse or refractory disease. Large-scale profiling studies have mainly focused on DLBCL at diagnosis, resolving different